Fluorescence Guided Surgery Systems Market - Top Companies and Manufacturers

Companies Dominating the Fluorescence Guided Surgery Systems Landscape

The dynamics of the global fluorescence guided surgery systems market are shifting towards adoption of next-generation technologies. Research institutions are continuously working to enable AI and machine learning into these devices to reduce operating time and cost. For instance, in December 2020, UCD Centre for Precision Surgery partnered with RCSI’s Department of Chemistry and IBM Research to develop AI-powered decision-making solution to deliver new fluorescence guidance techniques. The team of researchers aimed to penetrate AI methods to enhance specificity in real-time during colorectal cancer surgery while utilizing NIR FGS. Such innovative methods are inspiring key players, including:

Xinrui Medical Tech Co., Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Medtronic
Ziehm Imaging GmbH
VisionSense Technologies, Inc.
DEUtron Health
Synaptive Medical Inc.
AHN Biotechnologie GmbH
Fluoptics Technologies, Inc.
MultiPlanar Imaging, LLC
Accuray Incorporated
Stryker Corporation
Leica Microsystems GmbH
Hologic, Inc.
Getinge USA Sales, LLC
Lumicell, Inc.

Browse Key Market Insights with Data Illustration:

Fluorescence Guided Surgery Systems Market Size Report 2037

In the News

In September 2024, Stryker acquired NICO Corporation to expand the company’s portfolio in solutions for tumor resection and the treatment of intracerebral hemorrhage. The company invested a significant stake in this acquisition to promote its product pipeline including FIS devices worldwide.
In July 2024, Lumicell announced its acquisition of Category III CPT add-on code 0945T for intraoperative fluorescence imaging margin assessment from the American Medical Association. This additional approval was made to empower the global commercialization of its LumiSystem offerings.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the fluorescence guided surgery systems market was estimated at over USD 1.9 billion.

The market size for the fluorescence guided surgery systems market is projected to reach USD 4.1 billion by the end of 2037 expanding at a CAGR of 6.8% during the forecast period i.e., between 2025-2037.

The major players in the market are Xinrui Medical Tech Co., Ltd., Medtronic, Ziehm Imaging GmbH, VisionSense Technologies, Inc., DEUtron Health, Synaptive Medical Inc., AHN Biotechnologie GmbH, Fluoptics Technologies, Inc., MultiPlanar Imaging, LLC, Accuray Incorporated, Stryker Corporation, Leica Microsystems GmbH, Hologic, Inc., and others.

In terms of applications, the cancer surgery segment is anticipated to garner the largest market share of 63.4% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 58.5% by the end of 2037 and provide more business opportunities in the future.

Fluorescence Guided Surgery Systems Market - Top Companies and Manufacturers

Companies Dominating the Fluorescence Guided Surgery Systems Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the fluorescence guided surgery systems market?

What is the outlook for the fluorescence guided surgery systems market?

Who are the major players dominating the fluorescence guided surgery systems market?

Which application segment will capture the significant market share for the fluorescence guided surgery systems market by 2037?

Which region will provide more business opportunities for the growth of the fluorescence guided surgery systems market in the future?